Supplementary Tables S1-S4 from Screening for Tumor Microtube–Targeting Drugs Identifies PKC Modulators as Multipotent Inhibitors of Glioblastoma Progression

Supplementary Table 1. This table provides the inventory of 43 features extracted from our customized ilastik workflow along with their respective categories and descriptions. Supplementary Table 2. List of potential 71 anti-TM compounds tested in our in vitro 2DTM assay. Supplementary Table 3. Concentrations used for the potential 71 anti-TM compounds tested in our in vitro 2DTM assay. Supplementary Table 4. Values of the fold change of Total TM length, TMs per cell, and percentage of dead cells after treatment with the 71 compounds.